1. Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial. Issue 6 (26th February 2021) Authors: Shenderov, Eugene; Boudadi, Karim; Fu, Wei; Wang, Hao; Sullivan, Rana; Jordan, Alice; Dowling, Donna; Harb, Rana; Schonhoft, Joseph; Jendrisak, Adam; Carducci, Michael A.; Eisenberger, Mario A.; Eshleman, James R.; Luo, Jun; Drake, Charles G.; Pardoll, Drew M.; Antonarakis, Emmanuel S. Journal: Prostate Issue: Volume 81:Issue 6(2021) Page Start: 326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Perirectal hydrogel spacer placement prior to prostate radiation therapy using a probe-mounted needle guide. (July 2021) Authors: Meyer, Alexa R.; Dharmaraj, Divya; Harb, Rana; Pavlovich, Christian P.; Allaf, Mohamad E.; Gorin, Michael A. Journal: Clinical and translational radiation oncology Issue: Volume 29(2021) Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗